Zobrazeno 1 - 10
of 56
pro vyhledávání: '"R. Dubowy"'
Autor:
A. Sehgal, D. Hoda, P. A. Riedell, N. Ghosh, M. Hamadani, G. C. Hildebrandt, J. E. Godwin, P. Reagan, N. Wagner-Johnston, J. Essell, R. Nath, S. R. Solomon, R. Champion, E. Licitra, S. Fanning, N. Gupta, R. Dubowy, A. D’Andrea, L. Wang, L. I. Gordon
Publikováno v:
HemaSphere, Vol 6, Pp 159-160 (2022)
Externí odkaz:
https://doaj.org/article/4f00b6c8a2274e36b790862b61fe628b
Autor:
L. I. Gordon, D. Hoda, L. Shi, S. Guo, F. F. Liu, J. Braverman, R. Dubowy, L. Peng, A. Sehgal
Publikováno v:
HemaSphere, Vol 6, Pp 1591-1592 (2022)
Externí odkaz:
https://doaj.org/article/cfa8781d7ab14a86b9bf9268893f0d45
Autor:
A. Lightsey, L. Valdez, P. Chenaille, J. Sanders, N. Hakami, G. Rivard, K. McRedmond, T. John Gribble, S. Travis, V. Castle, M. Ragni, W. MacLaughlin, E. Czapek, P. Saidi, M. Koerper, Nigel S. Key, C. Manno, J. Cohen, J. Fahner, H. Stranczyniski, S. Adair, M. Hanna, M. Inwood, R. Seeler, D. Gnarra, P. De Alarcon, P. Phatak, B. L. Kroner, V. Anderson, E. Warner, A. Homans, Jeffrey H. Davis, M. Manco-Johnson, B. Ewenstein, Jorge Luiz Barbosa, P. Blatt, J. Lusher, Donna DiMichele, C. Johnson, R. Gruppo, P. Santiago-Borrero, G. Heggie, D. Barrand, J. Katz, M. Karpatkin, T. Loew, R. Kosinski, R. Dubowy, B. Konkle, M. Kajani, Casper Kasper, D. Lillicrap, S. Seremetis, M. Dugdale, Jonathan M. Ducore, J. Lazerson, J. Herst, P. Bockenstedt, Jerry S. Powell, C. Rosenfield, J. Hutter, S. Rubin, G. White, J. Addiego, J. Sexauer, W. Hanna, J. Teitel, P. Haut, G. Davignon, C. Kessler, J. Drown
Publikováno v:
Thrombosis and Haemostasis. 87:52-57
SummaryThe North American Immune Tolerance Registry was initiated to study of immune tolerance (ITT) in Canada and the United States with respect to: 1) therapeutic regimens in use for haemophilia A (HA) and B (HB) inhibitor patients; 2) therapeutic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c8b42a387f50a99937d085d2ff8cd03
https://doi.org/10.1055/s-0037-1612943
https://doi.org/10.1055/s-0037-1612943
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
T Vats, Peter D. Sadowitz, Bradley H Pollock, R Dubowy, W P Bowman, Vita J. Land, Howard J. Weinstein, R T Parmley, A Souid, C Pratt
Publikováno v:
Journal of Clinical Oncology. 12:1969-1973
PURPOSE The purpose of this phase I study was to determine the toxicities and response to continuous infusion carboplatin in combination with a fixed dose of etoposide (VP-16) in children with refractory acute leukemia. PATIENTS AND METHODS From Janu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10a1fd759479a2fccc14480cb748fefa
https://doi.org/10.1200/jco.1994.12.9.1969
https://doi.org/10.1200/jco.1994.12.9.1969
Autor:
Michael E. Harris, Yaddanapudi Ravindranath, Susumu Inoue, AK Ritchey, R Dubowy, A Chauvenet, E. Abella, CS Alvarado, Jeffrey P. Krischer, J Wiley
Publikováno v:
Blood. 80:2210-2214
The treatment of acute myeloid leukemia (AML) in children with Down's syndrome (DS) has engendered considerable controversy. Because of the concerns for toxicity and increased rate of infections, treatment approaches varied considerably in the past w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::248c33c3098a134724ccb578a1b64932
https://doi.org/10.1182/blood.v80.9.2210.2210
https://doi.org/10.1182/blood.v80.9.2210.2210
Autor:
J M, Hill, A B, Kornblith, D, Jones, A, Freeman, J F, Holland, A S, Glicksman, J M, Boyett, B, Lenherr, M L, Brecher, R, Dubowy, F, Kung, H, Maurer, J C, Holland
Publikováno v:
Cancer. 82(1)
Although previous research has delineated medical, cognitive, and neuropsychologic late effects of central nervous system (CNS) prophylaxis for childhood acute lymphoblastic leukemia (ALL), it has been difficult to draw conclusions about the long ter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::17d0db31dc86eda5dfc38399d7846ddb
https://pubmed.ncbi.nlm.nih.gov/9428499
https://pubmed.ncbi.nlm.nih.gov/9428499
Autor:
Y, Ravindranath, E, Abella, J P, Krischer, J, Wiley, S, Inoue, M, Harris, A, Chauvenet, C S, Alvarado, R, Dubowy, A K, Ritchey
Publikováno v:
Blood. 80(9)
The treatment of acute myeloid leukemia (AML) in children with Down's syndrome (DS) has engendered considerable controversy. Because of the concerns for toxicity and increased rate of infections, treatment approaches varied considerably in the past w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::87313c69af0fa6b366f33106eeacd4c2
https://pubmed.ncbi.nlm.nih.gov/8499650
https://pubmed.ncbi.nlm.nih.gov/8499650
Autor:
R A, Krance, S C, Raimondi, R, Dubowy, J, Estrada, M, Borowitz, F, Behm, V J, Land, J, Pullen, A J, Carroll
Publikováno v:
Leukemia. 6(4)
Structural rearrangements involving the short arm of chromosome 12 occur in 10% of cases of childhood acute lymphoid leukemia. The translocation t(12;17)(p13;q21), an uncommon 12p abnormality, was identified in five of 2620 cases (0.2%) successfully
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f58590bad2e8c9ddcce62ad5f2324777
https://pubmed.ncbi.nlm.nih.gov/1534130
https://pubmed.ncbi.nlm.nih.gov/1534130
Publikováno v:
Journal of Clinical Oncology. 27:e14549-e14549
e14549 Background: Sorafenib is a multikinase inhibitor currently approved by the FDA for the treatment of advanced renal-cell carcinoma (RCC) and unresectable hepatocellular carcinoma (HCC), and by the EMEA for the treatment of HCC and advanced RCC.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba36e32f0094c0cbb9aa4847fcb9aa73
https://doi.org/10.1200/jco.2009.27.15_suppl.e14549
https://doi.org/10.1200/jco.2009.27.15_suppl.e14549